Abstract
Chronic synovitis in severe hemophilia is a painful debilitating condition eventually affecting greater than 20% severe hemophilia patients in developing countries. Though this complication is all but eliminated in the countries with advanced hemophilia care and having access to generous factor concentrate replacement, the same can not be said for 80% of the hemophilia patients in the world who live in developing countries. In developing countries chronic synovitis can be treated conservatively with short course of steroid, factor replacement, physiotherapy and splintage. Failing this, chemical or radioactive synoviorthesis give worthwhile remission and relief in 70–80% of the severely affected patients who fail to respond to conservative therapy. We found a short course of Cox-2 (etoricoxib) inhibitor to be an extremely useful adjunct. The role of d-Pencillamine, Thalidomide and inhibitors of matrix metalloproteinases needs to be explored. HLA-B27 was found to be strongly associated with chronic synovitis in hemophilia in one of the studies and this marker in a hemophilia patient may suggest need for more intensive replacement and other therapy in these patients to prevent chronic synovitis.
Keywords: Chronic synovitis, Developing countries, HLA-B27, Radioactive synoviorthesis
Full Text
The Full Text of this article is available as a PDF (436.7 KB).
References
- 1.Rodriguez-Marchan E.C. The destructive capabilities of synovium in the hemophilic joint. Hemophilia. 1998;4:506–510. doi: 10.1046/j.1365-2516.1998.440506.x. [DOI] [PubMed] [Google Scholar]
- 2.Ghosh K., Shankarkumar U., Shetty S., Mohanty D. Chronic Synovitis and HLA B27 in patient with severe hemophilia. Lancet. 2003;261:933–934. doi: 10.1016/S0140-6736(03)12763-8. [DOI] [PubMed] [Google Scholar]
- 3.Shankarkumar U., Ghosh K., Mohanyt D., Novel H.L.A. B*2714, B*2708 and allele associations in seronegative spondarthritis patients and haemiophilia patients with chronic synovitis in India. Tissue Antigen. 2003;61:1–4. doi: 10.1034/j.1399-0039.2003.610101.x. [DOI] [PubMed] [Google Scholar]
- 4.Fischer K., Astermark A., Born J.G., Ljung R., Berntrop E., Grobee D.E., Berg H.M. Prophylactic treatment for hemophilia: comparison of an intermediate and high dose regimen. Hemophilia. 2002;8:753–760. doi: 10.1046/j.1365-2516.2002.00694.x. [DOI] [PubMed] [Google Scholar]
- 5.Klein K.S., Aland C.M., Kim H.C., Eisele J., Saidi P. Long term Follow up of arthroscopic synovecsomy for chronic hemophilic synovitis. 1987;3:231–236. doi: 10.1016/s0749-8063(87)80116-0. [DOI] [PubMed] [Google Scholar]
- 6.Montane I., Mc Collough N.C., 3rd, Lian E.C. Synovectomy of the kenee for hemophilic arthropathy. J Bone Joint Surg AM. 1986;68(2):210–16. [PubMed] [Google Scholar]
- 7.Heijnen L., editor. Recent Advances in Rehabilitation in hemophilia. UK: Medical Edncation Network Survey; 1995. [Google Scholar]
- 8.Muller S., Kurth A.A., Hovy L. Conservative management of hemophilic arthropathy. Orthopade. 1999;28:347–355. doi: 10.1007/s001320050357. [DOI] [PubMed] [Google Scholar]
- 9.Kale J.S., Ghosh K., Mohanty D., Pathare A.V., Jijina F. Use of the dual force systems to correct chronic knee deformities due to severe hemophilia. Hemophilia. 2000;6:177–180. doi: 10.1046/j.1365-2516.2000.00396.x. [DOI] [PubMed] [Google Scholar]
- 10.Yates P., Cornwell J., Scott J.L., Atkiuis R.M. Treatment of hemophilia flexion intermittent compression system. Br J Haematol. 1992;82:384–387. doi: 10.1111/j.1365-2141.1992.tb06433.x. [DOI] [PubMed] [Google Scholar]
- 11.Ghosh K. Management of Hemophilia and its complications in developing countries. Clin Lab Haem. 2004;26:243–251. doi: 10.1111/j.1365-2257.2004.00590.x. [DOI] [PubMed] [Google Scholar]
- 12.Shupak R., Teitel J., Garvey M.B., Freedman J. Intra articular methge pred nisoloke therapy in hemophilic arthropathy. Am J Haematol. 1988;27:26–29. doi: 10.1002/ajh.2830270107. [DOI] [PubMed] [Google Scholar]
- 13.Corrigan J.J., Jr, Kolba K.S., Gall E.P., Trombley J., Damiano M.L., Meredith K., Jeter M. Treatment of hemophilic arthritis with D-phenicillamine: a preliminary report. Am J Hamatol. 1985;19:255–264. doi: 10.1002/ajh.2830190307. [DOI] [PubMed] [Google Scholar]
- 14.Corrigan J.J., Jr, Damiano M.L., Leissuger C., Wulff K. Treatment of Chronic Hemophilic synovitis in humans with D-Penicillamuia. Hamophilia. 2003;9:64–68. doi: 10.1046/j.1365-2516.2003.00676.x. [DOI] [PubMed] [Google Scholar]
- 15.Rodriguez-Merchan E.C. Management of musculoskeletal complications of haemophlia. Semin Thromb Hemost. 2003;29:87–96. doi: 10.1055/s-2003-37942. [DOI] [PubMed] [Google Scholar]
- 16.Cavglia H.A., Fernandez-Pallazi F., Galatro G., Perez-Biaanco R. Chemical synociorthesis with rifampicin in hemophilia. Haemophlia. 2001;7(suppl2):26–30. doi: 10.1046/j.1365-2516.2001.00105.x. [DOI] [PubMed] [Google Scholar]
- 17.Rodriguez-Merchan E.C. Methods to treat chronic hemophilia synocitis. Hemophilia. 2001;7:1–5. doi: 10.1046/j.1365-2516.2001.00481.x. [DOI] [PubMed] [Google Scholar]
- 18.Silva M., Luck J.V., Jr, Single M.E. 32p chronic phosphate radiosynovectomy for chronic hemophilic synovitis. Hemophilia. 2001;7:40–49. doi: 10.1046/j.1365-2516.2001.00109.x. [DOI] [PubMed] [Google Scholar]